Cargando…

Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile

Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Younis, Rania H., Ghita, Ioana, Elnaggar, Manar, Chaisuparat, Risa, Theofilou, Vasileios Ionas, Dyalram, Donita, Ord, Robert A., Davila, Eduardo, Tallon, Luke J., Papadimitriou, John C., Webb, Tonya J., Bentzen, Søren M., Lubek, Joshua E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991916/
https://www.ncbi.nlm.nih.gov/pubmed/33776991
http://dx.doi.org/10.3389/fimmu.2021.596646
_version_ 1783669270379495424
author Younis, Rania H.
Ghita, Ioana
Elnaggar, Manar
Chaisuparat, Risa
Theofilou, Vasileios Ionas
Dyalram, Donita
Ord, Robert A.
Davila, Eduardo
Tallon, Luke J.
Papadimitriou, John C.
Webb, Tonya J.
Bentzen, Søren M.
Lubek, Joshua E.
author_facet Younis, Rania H.
Ghita, Ioana
Elnaggar, Manar
Chaisuparat, Risa
Theofilou, Vasileios Ionas
Dyalram, Donita
Ord, Robert A.
Davila, Eduardo
Tallon, Luke J.
Papadimitriou, John C.
Webb, Tonya J.
Bentzen, Søren M.
Lubek, Joshua E.
author_sort Younis, Rania H.
collection PubMed
description Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with head and neck squamous cell carcinoma (HNSCC). Paired peripheral blood and tumor tissue samples of 104 patients with HNSCC were collected at the same time point to allow for real time analysis. Scoring of the histological inflammatory subtype (HIS) was carried out using Sema4D immunohistochemistry on the tumor tissue. sSema4D was detected in plasma using direct ELISA assay. Defining elevated sSema4D as values above the 95(th) percentile in healthy controls, our data showed that sSema4D levels in plasma were elevated in 25.0% (95% CI, 16.7–34.9%) of the patients with HNSCC and showed significant association with HIS immune excluded (HIS-IE) (p = 0.007), Sema4D(+ve) tumor cells (TCs) (p = 0.018) and PD-L1(+ve) immune cells (ICs) (p = 0.038). A multi-variable logistic regression analysis showed that HIS was significantly (P = 0.004) associated with elevated sSema4D, an association not explained by available patient-level factors. Using the IO-360 nanoString platform, differential gene expression (DGE) analysis of 10 HNSCC tumor tissues showed that patients with high sSema4D in plasma (HsS4D) clustered as IFN-γ negative tumor immune signature and were mostly HIS-IE. The IC type in the HsS4D paired tumor tissue was predominantly myeloid, while the lymphoid compartment was higher in the low sSema4D (LsS4D). The Wnt signaling pathway was upregulated in the HsS4D group. Further analysis using the IO-360, 770 gene set, showed significant non-inflamed profile of the HsS4D tumors compared to the LsS4D. In conclusion, our data reveals an association between sSema4D and the histological inflammatory subtype.
format Online
Article
Text
id pubmed-7991916
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79919162021-03-26 Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile Younis, Rania H. Ghita, Ioana Elnaggar, Manar Chaisuparat, Risa Theofilou, Vasileios Ionas Dyalram, Donita Ord, Robert A. Davila, Eduardo Tallon, Luke J. Papadimitriou, John C. Webb, Tonya J. Bentzen, Søren M. Lubek, Joshua E. Front Immunol Immunology Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with head and neck squamous cell carcinoma (HNSCC). Paired peripheral blood and tumor tissue samples of 104 patients with HNSCC were collected at the same time point to allow for real time analysis. Scoring of the histological inflammatory subtype (HIS) was carried out using Sema4D immunohistochemistry on the tumor tissue. sSema4D was detected in plasma using direct ELISA assay. Defining elevated sSema4D as values above the 95(th) percentile in healthy controls, our data showed that sSema4D levels in plasma were elevated in 25.0% (95% CI, 16.7–34.9%) of the patients with HNSCC and showed significant association with HIS immune excluded (HIS-IE) (p = 0.007), Sema4D(+ve) tumor cells (TCs) (p = 0.018) and PD-L1(+ve) immune cells (ICs) (p = 0.038). A multi-variable logistic regression analysis showed that HIS was significantly (P = 0.004) associated with elevated sSema4D, an association not explained by available patient-level factors. Using the IO-360 nanoString platform, differential gene expression (DGE) analysis of 10 HNSCC tumor tissues showed that patients with high sSema4D in plasma (HsS4D) clustered as IFN-γ negative tumor immune signature and were mostly HIS-IE. The IC type in the HsS4D paired tumor tissue was predominantly myeloid, while the lymphoid compartment was higher in the low sSema4D (LsS4D). The Wnt signaling pathway was upregulated in the HsS4D group. Further analysis using the IO-360, 770 gene set, showed significant non-inflamed profile of the HsS4D tumors compared to the LsS4D. In conclusion, our data reveals an association between sSema4D and the histological inflammatory subtype. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991916/ /pubmed/33776991 http://dx.doi.org/10.3389/fimmu.2021.596646 Text en Copyright © 2021 Younis, Ghita, Elnaggar, Chaisuparat, Theofilou, Dyalram, Ord, Davila, Tallon, Papadimitriou, Webb, Bentzen and Lubek http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Younis, Rania H.
Ghita, Ioana
Elnaggar, Manar
Chaisuparat, Risa
Theofilou, Vasileios Ionas
Dyalram, Donita
Ord, Robert A.
Davila, Eduardo
Tallon, Luke J.
Papadimitriou, John C.
Webb, Tonya J.
Bentzen, Søren M.
Lubek, Joshua E.
Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title_full Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title_fullStr Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title_full_unstemmed Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title_short Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
title_sort soluble sema4d in plasma of head and neck squamous cell carcinoma patients is associated with underlying non-inflamed tumor profile
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991916/
https://www.ncbi.nlm.nih.gov/pubmed/33776991
http://dx.doi.org/10.3389/fimmu.2021.596646
work_keys_str_mv AT younisraniah solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT ghitaioana solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT elnaggarmanar solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT chaisuparatrisa solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT theofilouvasileiosionas solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT dyalramdonita solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT ordroberta solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT davilaeduardo solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT tallonlukej solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT papadimitrioujohnc solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT webbtonyaj solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT bentzensørenm solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile
AT lubekjoshuae solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile